等待開盤 12-16 09:30:00 美东时间
-0.530
-0.97%
Vita Coco announced a new partnership with Rush Soccer, becoming the Official Hydration Partner. This collaboration aims to provide young athletes with cleaner, more natural hydration options. Vita Coco's electrolytes are 3.5 times higher than leading sports drinks, offering better hydration and wellness support. The partnership includes product integration at events, hydration stations, and educational content. Rush Soccer, with over 55,000 play...
12-09 14:00
As of Nov. 26, 2025, two stocks in the consumer staples sector could be flashin...
11-26 21:46
今日重点评级关注:HC Wainwright & Co.:维持BiomX"买入"评级,目标价从15美元升至26美元;Clear Street:维持Diversified Energy"买入"评级,目标价从23美元升至25美元
11-26 10:07
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从4美元升至9美元;BTIG:维持Cullinan Therapeutics"买入"评级,目标价从32美元升至38美元
11-25 10:27
Stephens & Co. analyst Jim Salera upgrades Vita Coco (NASDAQ:COCO) from Equal-Weight to Overweight and raises the price target from $40 to $58.
11-24 23:26
今日重点评级关注:Oppenheimer:维持Olema Pharmaceuticals"跑赢大市"评级,目标价从22美元升至45美元;Bernstein:维持Atlassian"跑赢大市"评级,目标价从290美元升至304美元
11-19 11:01
今日重点评级关注:HC Wainwright & Co.:维持Oncolytics Biotech"买入"评级,目标价从5美元升至10美元;HC Wainwright & Co.:维持Barinthus Biotherapeutics"买入"评级,目标价从3美元升至4美元
11-18 15:28
U.S. stocks were lower, with the Dow Jones index falling more than 100 points o...
11-18 00:39
B of A Securities analyst Bryan Spillane upgrades Vita Coco (NASDAQ:COCO) from Neutral to Buy and raises the price target from $48 to $54.
11-17 19:43
今日重点评级关注:Ascendiant Capital:维持NRX Pharmaceuticals"买入"评级,目标价从46美元升至47美元;富国银行:维持Kyverna Therapeutics"超配"评级,目标价从27美元升至31美元
10-31 10:25